IL17-hæmmere i rampelyset på EULAR 2023
/ Lars Erik Vølund Kristensen
Anti-infliximab antibodies led to poorer clinical outcomes
/ Marthe Kirkesæther Brun
EULAR 2023 – UPDATE
/ BestPractice Nordic
Vocational rehabilitation for people with inflammatory arthritis
/ Christina Merete Tvede Madsen